Early-onset alopecia universalis successfully treated with baricitinib in a toddler: A case report. [PDF]
Aleissa AI, Alsharif SM, Alsantli A.
europepmc +1 more source
The JAK1/2 Inhibitor Baricitinib Ameliorates Neuroinflammation and Symptoms in an Animal Model of Essential Tremor. [PDF]
Ilaghi M +7 more
europepmc +1 more source
Peripheral Immune Modulation in Atopic Dermatitis During Dupilumab or Baricitinib Treatment Is Limited, as Assessed by Proteomic, Transcriptomic, and Torque Teno Virus Analyses. [PDF]
Touborg T +7 more
europepmc +1 more source
JAK Inhibitors for Alopecia Areata: Approved Therapies, Efficacy, and Unanswered Questions. [PDF]
Wu ZX +10 more
europepmc +1 more source
Minoxidil Sulfate Regulates JAK/STAT Signalling and Mitochondrial Function in Alopecia Areata. [PDF]
Shin JM +5 more
europepmc +1 more source
Feasibility of stepwise baricitinib tapering after complete response in alopecia areata: A real-world observational cohort study. [PDF]
Seo HR, Kim DY.
europepmc +1 more source
AD-REAL: A Prospective, Multinational, Observational Cohort Study of Clinical Effectiveness and Treatment Discontinuation of Oral Systemics for Moderate-to-Severe Atopic Dermatitis. [PDF]
Augustin M +10 more
europepmc +1 more source
Effect of JAK Inhibitors on Fatigue and Sleep Quality in Patients with Rheumatoid Arthritis: A Narrative Review. [PDF]
Kowalska A +5 more
europepmc +1 more source
Baricitinib Inhibits the Aggressive Phenotype of Synovial Fibroblasts in Rheumatoid Arthritis via the JAK-STAT3-EGR1 Axis. [PDF]
Wang J +9 more
europepmc +1 more source
Refractory IgG4-related skin disease successfully treated with intravenous methylprednisolone and baricitinib. [PDF]
Jiang J +4 more
europepmc +1 more source

